| Daniel Gray, MD | |
|
601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 | |
| (585) 275-4517 | |
| (585) 442-9201 |
| Full Name | Daniel Gray |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 31 Years |
| Location | 601 Elmwood Ave, Rochester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295779932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 200474 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Strong Health Dialysis-clinton Crossings | Rochester, NY | Dialysis facility |
| Highland Hospital | Rochester, NY | Hospital |
| Strong Memorial Hospital | Rochester, NY | Hospital |
| F F Thompson Hospital | Canandaigua, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Strong Renal Group | 7315851672 | 44 |
News Archive
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
Genetic Analysis, a leading Microbiome MDx specialist, today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief.
In a potentially precedent-setting ruling, the Washington State Supreme Court determined last week that psychiatric boarding — the process by which patients are admitted to a hospital, but remain in the emergency department for hours, even days, until psychiatric beds become available — is unconstitutional and violates the state's Involuntary Treatment Act.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
› Verified 2 days ago
| Entity Name | Strong Renal Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881641470 PECOS PAC ID: 7315851672 Enrollment ID: O20031119000537 |
News Archive
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
Genetic Analysis, a leading Microbiome MDx specialist, today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief.
In a potentially precedent-setting ruling, the Washington State Supreme Court determined last week that psychiatric boarding — the process by which patients are admitted to a hospital, but remain in the emergency department for hours, even days, until psychiatric beds become available — is unconstitutional and violates the state's Involuntary Treatment Act.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
› Verified 2 days ago
| Entity Name | Highland Hospital Of Rochester |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902221518 PECOS PAC ID: 5496641631 Enrollment ID: O20070301000229 |
News Archive
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
Genetic Analysis, a leading Microbiome MDx specialist, today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief.
In a potentially precedent-setting ruling, the Washington State Supreme Court determined last week that psychiatric boarding — the process by which patients are admitted to a hospital, but remain in the emergency department for hours, even days, until psychiatric beds become available — is unconstitutional and violates the state's Involuntary Treatment Act.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Gray, MD 601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 Ph: (585) 275-1554 | Daniel Gray, MD 601 Elmwood Ave, Box Med, Rochester, NY 14642-0001 Ph: (585) 275-4517 |
News Archive
Bristol-Myers Squibb Company today announced results from a Phase 2 and a Phase 1b study of its investigational PD-1 immune checkpoint inhibitor nivolumab in patients with advanced or metastatic renal cell carcinoma (RCC), commonly known as kidney cancer.
Genetic Analysis, a leading Microbiome MDx specialist, today announced the publication of a new study in the peer-reviewed journal Digestive Disease and Sciences showing the results of using its GA-map Dysbiosis Test for identifying IBS patients who respond to the FODMAP diet and thus receive symptom relief.
In a potentially precedent-setting ruling, the Washington State Supreme Court determined last week that psychiatric boarding — the process by which patients are admitted to a hospital, but remain in the emergency department for hours, even days, until psychiatric beds become available — is unconstitutional and violates the state's Involuntary Treatment Act.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
› Verified 2 days ago
Amy Bodrog, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-4020 Fax: 585-922-4622 | |
Natalia Golub, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 30 Hagen Dr Ste 320, Rochester, NY 14625 Phone: 585-922-1900 | |
Hanan Ibrahim Sheikh Ibrahim, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1415 Portland Ave Ste 200, Rochester, NY 14621 Phone: 585-922-0390 Fax: 585-922-0395 | |
Numra Aslam Bajwa, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 585-922-5067 Fax: 716-862-1871 | |
Dr. Prakash Upreti, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1425 Portland Ave, Rochester, NY 14621 Phone: 295-029-8769 | |
William M Valenti, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 259 Monroe Avenue, Rochester, NY 14607 Phone: 585-545-7200 Fax: 585-244-6456 | |
Ms. Terri Winter, N.P. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 250 Crittenden Blvd, Box 617, Rochester, NY 14642 Phone: 585-275-2662 Fax: 585-276-0149 |